Pandemic Preparedness and Response
Acronym
PANDEM-2
Description of the granted funding
PANDEM-2 implements and demonstrates the most important novel concepts and IT systems to improve the capacity of European pandemic planning and response. Following the PANDEM project (with the same coordinator and many shared partners) and extensive subsequent stakeholder engagement, research and prioritisation, PANDEM-2 meets the real-world needs of public health agencies responsible for pandemics (‘pandemic managers’) and first responders across Europe.
PANDEM-2 will enable and demonstrate the capture and integration of pandemic-relevant data from international systems (Go.Data outputs, EWRS, TESSy, etc.), participative surveillance (Influenzanet, Studybugs, etc.), fron laboratory (next generation sequencing) systems and from social media (Twitter, Reddit). This data will be accessible and can be analysed via an online dashboard, designed and built to support the specific needs of pandemic managers. Additional high-priority tools for pandemic spread prediction, visual analytics and resources management, including workforce capacity mapping, will improve preparedness and planning, and enable pandemic managers to be as well positioned as possible for a pandemic when it comes.
In order to test the system, while also networking and building relationships across borders and organisations, pandemic managers and first responders from multiple Member States will work together in EU-wise demonstrations, planning and responding to several pandemic scenarios, from Ebola to SARS/MERS CoV, to pandemic influenza.
Pandemic communications, highlighted as a key capability gap, will be addressed by resource creation, training and evaluation.
Show moreStarting year
2021
End year
2023
Granted funding
STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM (NL)
307 285 €
Participant
CLARISOFT TECHNOLOGIES ROM SRL (RO)
991 732.51 €
Participant
TRILATERAL RESEARCH LIMITED (IE)
118 212.5 €
Third party
ASSOCIAZIONE DELLA CROCE ROSSA ITALIANA (IT)
213 449.58 €
Participant
TRILATERAL RESEARCH LTD (UK)
148 925 €
Participant
EPICONCEPT UK LIMITED (UK)
43 884.75 €
Third party
INEM (PT)
221 412.5 €
Participant
FOLKHALSOMYNDIGHETEN (SE)
328 783.75 €
Participant
EPICONCEPT (FR)
616 497.35 €
Participant
INSTITUTUL NATIONAL DE SANATATE PUBLICA (RO)
122 599.8 €
Participant
MINISTERIO DA SAUDE - REPUBLICA PORTUGUESA (PT)
61 650 €
Third party
OSTERREICHISCHES ROTES KREUZ (AT)
184 188.48 €
Participant
PINTAIL LTD (IE)
207 375 €
Participant
INSTITUTO NACIONAL DE SAUDE DR. RICARDO JORGE (PT)
265 225 €
Participant
Carr Communications Limited (IE)
301 000 €
Participant
ROBERT KOCH-INSTITUT (DE)
540 922.7 €
Participant
ISTITUTO PER L'INTERSCAMBIO SCIENTIFICO (IT)
266 250 €
Participant
NATIONAL UNIVERSITY OF IRELAND GALWAY (IE)
2 050 801.25 €
Coordinator
UNIVERSITE CATHOLIQUE DE LOUVAIN (BE)
715 519.13 €
Participant
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE)
449 515 €
Participant
RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU (NL)
342 403.75 €
Participant
Amount granted
8 705 650 €
Funder
European Union
Funding instrument
Innovation action
Framework programme
Horizon 2020 Framework Programme
Call
Programme part
Secure societies - Protecting freedom and security of Europe and its citizens (5452 Increase Europe's resilience to crises and disasters (5457 )
Topic
Demonstration of novel concepts for the management of pandemic crises (SU-DRS05-2019Call ID
H2020-SU-SEC-2019 Other information
Funding decision number
883285
Identified topics
covid, pandemic, vaccines